Deciphera Pharmaceuticals
Deciphera is seeking a dynamic Senior Director, Program Lead to drive the strategy and operations for late preclinical, clinical, and commercial assets. This role involves leading cross-functional teams to develop and execute global program strategies, manage development timelines, and ensure alignment with corporate objectives. The position requires a seasoned leader with extensive drug development experience to oversee asset strategy and life-cycle management projects.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2003
Deciphera Pharmaceuticals, now a member of ONO Pharma, is a biopharmaceutical company dedicated to discovering, developing, and commercializing switch-control kinase inhibitors and other targeted therapies to improve outcomes for people with cancer. The company's portfolio includes approved medicines QINLOCK (ripretinib) for advanced gastrointestinal stromal tumor and ROMVIMZA (vimseltinib), as well as a broad pipeline of clinical-stage candidates such as tirabrutinib and sapablursen. Driven by a patient-inspired mission to defeat cancer, Deciphera focuses on addressing key mechanisms of tumor and drug resistance through its proprietary discovery platform.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deciphera Pharmaceuticals.
Director Drug Development Program Management
Regeneron Pharmaceuticals
Director, Development Program Management
Regeneron Pharmaceuticals
Director, Development Program Management
Regeneron Pharmaceuticals
Sr. Director/Executive Director, Program Leader, CLYM116
Climb Bio
Director, Development Program Management
Regeneron Pharmaceuticals
Director, Development Program Management
Regeneron Pharmaceuticals